SMC4 and central nervous system cancer: Through integrated bioinformatic analysis, SMC4 was also identified as a potential prognostic biomarker for low-grade glioma patients, which functions to promote cell proliferation by repairing replication damage, and the expression of SMC4 could be transcriptionally regulated by MYB or directly by miR-433-3p (42, 43).